Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantB-cell neoplasm, Blood-Borne Infections, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, RNA Virus Infections, T-cell non-Hodgkin lymphoma, Tumor Virus Infections, Urogenital Diseases, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm, plasmablastic lymphoma, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 1 / Phase 22026-05-18NCT02797470

3 results · Page 1 of 1

Swipe the table sideways for more columns.

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
UC San Diego Moores Cancer CenterLa JollaUnited States199
UCSF Medical Center-ParnassusSan FranciscoUnited States1
University of California Davis Comprehensive Cancer CenterSacramentoUnited States299